Studies Indicate Elmiron Causes Early-Onset Age-Related Macular Degeneration (AMD)

Lawsuits claim that Johnson & Johnson willfully ignored Elmiron's vision damage side effects

Monday, October 5, 2020 - Forbes online magazine recently published an article warning people who are taking the drug Elmiron that they may experience severe eyesight problems and even blindness. The basis of the article is the most recent scientific study that claims to have proof that the drug causes eyesight problems in the long-term, particularly difficulty reading in less than optimal lighting conditions. Elmiron is the only drug approved by the FDA to treat a woman's painful bladder condition known as interstitial cystitis (IC). The drug is said to cause damage to the light-sensing tissue on the back of the eye called the retina. According to Forbes, A 2018 study by Nieraj Jain, M.D, Assistant Professor of Ophthalmology, Emory University School of Medicine, Emory Eye Center, "reported reading difficulty and visual changes-especially under dark conditions-among six patients who had been taking the drug, Elmiron (pentosan polysulfate sodium, PPS) for an average of 15 years (range of 12-20 years)." Dr. Jain studied 6 Elmiron patients that had no previous history of eyesight problems and found, "(all 6 patients) had atypical changes in their macula, the central part of the retina that allows us to have clear central vision. The patients described difficulty reading in dim light and diminished central visual acuity." Also, in May of 2019, an additional 10 Elmiron patients were studied and found to have the same eyesight damage. The results of the study were presented at the 2019 annual meeting of the American Urological Association, according to Forbes. A similar study by Kaiser Permanente was presented to the American Association of Ophthalmologists. The study also concluded that Elmiron may cause early-onset age-related macular degeneration (AMD). OrthoElmiron.com describes the side effect of the drug as"... difficulty reading, slow adjustment to low or reduced light environments, and blurred vision."

Johnson and Johnson, the maker of Elmiron, is accused of engaging in serious and unethical business practices for failing to warn the public of the dangers of Elmiron blindness. Lawsuits filed allege the company should have known or had the responsibility to know of these life-altering adverse side effects. Elmiron eye lawyers represent people with Elmiron eye damage and offer a free consultation.

Johnson & Johnson earns hundreds of millions of dollar from its Elmiron monopoly as more and more women are put on the drug every year. Up to 8 million women in the United States suffer from IC and are taking Elmiron. Studies estimate that as many as 25% of all Elmiron patients may be affected by Elmiron vision loss and many are hiring an Elmiron Blindness attorney to help them file lawsuits against Johnson & Johnson for monetary compensation for losses suffered by incurring medical expenses, lost wages, pain, and suffering and many other damages one suffers as a result of losing one's vision. If you or a loved one have been on Elmiron for over five years, you should have your vision checked for macular degeneration and if present talk to an Emiron Vision Damage Attorney to file a claim.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.